Daytrana: Adverse Events

Number (%) of Subjects With Commonly Reported Adverse Reactions (≥ 1% in the Daytrana Group) in 7-week Placebo-controlled Studies in Either Children or Adolescents—Safety Population

^*Six subjects had affect lability, all judged as mild and described as increased emotionality, sensitive emotionally, emotional instability, emotional lability, and intermittent emotional.

Proven Symptom Management

Daytrana offers long-acting efficacy for children and adolescents ages 6-17.

Learn more about Daytrana management of ADHD symptoms

A Long Acting Patch

A 9-hour wear time that delivers 10 hours of efficacy.

Learn more about the wear time of Daytrana

Video: Applying and Removing the Patch

Get patch application tips for parents and caregivers.

Watch the video

Daytrana and the Graphic Design are registered trademarks of Noven Therapeutics, LLC.

For information visit www.Daytrana.com or call 1-877-567-7857.

Please see our online privacy policy for more information. While Noven Therapeutics, LLC makes reasonable efforts to include accurate, up-to-date information, Noven makes no warranties or representations as to its accuracy. Noven assumes no liability for any omissions in the content of this Web site.

You are about to leave Daytrana.com

Please be advised that Noven Therapeutics has no control over the content or presentation of the site you are about to view. Click the "Continue" button to proceed.

To return to Daytrana.com click "Cancel," or close this window.

Cancel Continue

Online Privacy Policy